Eurofins agrees to buy US analytical services firm Advantar Laboratories

By Gareth Macdonald contact

- Last updated on GMT

Eurofins to buy Advantar Laboratories
Eurofins to buy Advantar Laboratories

Related tags: Biotechnology, Chemistry

Eurofins Scientific has agreed to buy analytical services firm Advantar Laboratories in its latest deal in the pharmaceutical space.

The agreement - financial terms of which were not disclosed – will see San Diego, US-based Advantar’s GLP and cGMP laboratory become part of Eurofins' network. The 50 staff employed at the facility will also join Eurofins.

Advantar provides analytical services to the pharmaceutical industry, but its capabilities in biopharmaceutical analysis is where it stands out according to Neal McCarthy from Fairmount Partners, the Philadelphia-based bank which represented Advantar shareholders.

Advantar is strong at both analytical testing and formulation and also has a small manufacturing operation that could be used to make clinical trial supplies or small scale commercial products​” he said, adding the firm also has “expertise is in large molecule projects, which is less common.”

McCarthy – who brokered the sale of US environmental testing firm Air Toxics to Eurofins in 2012 - said Advantar’s proximity to West Coast industry customers was a big selling point. He also predicted Eurofins would hire additional staff and expand the lab.

The acquisition is the latest in series of laboratory takeovers made by Eurofins, many of which have been pharmaceutical services firms.

For example, last month Eurofins bought Australian QC company ams Laboratories – which provides analytical and cGMP Quality Control (QC) services provider for biopharmaceuticals - just two months after ​buying another QC testing firm – Sinensis Life Science BV​;

In June last year Eurofins announced it would pay $40m (€35m) for a 75% stake in Emory Genetics Laboratory (EGL) – a specialist provider of genetic testing service – in a deal with current owner Emory University's School of Medicine.

A week before that the firm bought French testing services firm Biomnis from Bio Alfras SAS for €220m ($249m) and two weeks after it announced a €150m investment in lab group BioAccess.

And a month before that Eurofins acquired US-based testing services specialist Diatherix Laboratories.

Related news

Show more

Related products

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars